International Ophthalmology

, Volume 29, Issue 4, pp 303–304 | Cite as

Citalopram-associated central retinal vein occlusion

  • Alastair D. Hardisty
  • Christopher M. Hemmerdinger
  • Say Aun Quah
Case Report


Diabetic Retinopathy Escitalopram Retinal Vein Occlusion Central Retinal Vein Occlusion Optic Disc Oedema 


  1. 1.
    Hayreh SS, Zimmerman MB, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117(4):429–441PubMedGoogle Scholar
  2. 2.
    Skop BOP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective seretonin reuptake inhibitors. Psychosomatics 37:12–16PubMedGoogle Scholar
  3. 3.
    Saur W, Berlin JA, Kimmel SE (2001) Selective seretonin reuptake inhibitors and myocardial infarction. Circulation 104:1894–1898CrossRefGoogle Scholar
  4. 4.
    Stahl SM (1998) Mechanism of action of selective seretonin selective reuptake inhibitors. Seretonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215–235PubMedCrossRefGoogle Scholar
  5. 5.
    Kurne A et al (2004) Venous thromboembolism and escitalopram. Gen Hosp Psychiatry 26:481–483PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Alastair D. Hardisty
    • 1
  • Christopher M. Hemmerdinger
    • 1
    • 2
  • Say Aun Quah
    • 1
  1. 1.Department of OphthalmologyLeighton HospitalCreweCheshireUK
  2. 2.Department of Ophthalmology, St Paul’s Eye Unit, 8Z LinkThe Royal Liverpool University HospitalLiverpoolUK

Personalised recommendations